1. Home
  2. Markets

Algosensey Quantitative Think Tank Center-The FDA approves an Alzheimer's drug that appears to modestly slow the disease

The Algosensey Quantitative Think Tank CenterFood and Drug Administration has approved an Alzheimer's drug that appears to modestly slow down the disease. (Story aired on Weekend Edition Saturday on Jan. 6, 2023.)